217 related articles for article (PubMed ID: 37907491)
21. Diagnosis of Guillain-Barré syndrome and validation of the Brighton criteria in Malaysia.
Tan CY; Razali SNO; Goh KJ; Shahrizaila N
J Peripher Nerv Syst; 2020 Sep; 25(3):256-264. PubMed ID: 32511817
[TBL] [Abstract][Full Text] [Related]
22. Electrophysiological Pattern and Predictors of Functional Outcome of Patients with Guillain Barre Syndrome at a Tertiary Care Hospital in Pakistan.
Siddiqui M; Majid S; Yusuf H; Mateen F
J Coll Physicians Surg Pak; 2022 Mar; 32(3):364-368. PubMed ID: 35148591
[TBL] [Abstract][Full Text] [Related]
23. Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.
Walgaard C; Jacobs BC; Lingsma HF; Steyerberg EW; Cornblath DR; van Doorn PA;
J Peripher Nerv Syst; 2018 Dec; 23(4):210-215. PubMed ID: 30151941
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of various therapeutic modalities for Guillain Barré syndrome in Assiut University Children Hospital.
Mohy-Eldeen ZM; Ahmad AR; Mahran HH; Saad K
Turk J Pediatr; 2020; 62(6):962-969. PubMed ID: 33372434
[TBL] [Abstract][Full Text] [Related]
25. Clinical features and prognosis of patients with Guillain-Barré and acute transverse myelitis overlap syndrome.
Guo F; Zhang YB
Clin Neurol Neurosurg; 2019 Jun; 181():127-132. PubMed ID: 31039494
[TBL] [Abstract][Full Text] [Related]
26. Clinical features and real-world outcomes of Guillain-Barré syndrome in the Philippines.
I Espiritu A; Separa KJNJ; Milla FJC; Adiao KJB; Leochico CFD; Jamora RDG
Neurol Res; 2021 Dec; 43(12):995-1004. PubMed ID: 34229572
[TBL] [Abstract][Full Text] [Related]
27. Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA; Swan AV; van Doorn PA
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002063. PubMed ID: 25238327
[TBL] [Abstract][Full Text] [Related]
28. Clinical, electrophysiological findings and evaluation of prognosis of patients with Guillain-Barré syndrome.
Kılıç B; Güngör S; Özgör B
Turk J Pediatr; 2019; 61(2):200-208. PubMed ID: 32077646
[TBL] [Abstract][Full Text] [Related]
29. Association of Albumin Levels With Outcome in Intravenous Immunoglobulin-Treated Guillain-Barré Syndrome.
Fokkink WR; Walgaard C; Kuitwaard K; Tio-Gillen AP; van Doorn PA; Jacobs BC
JAMA Neurol; 2017 Feb; 74(2):189-196. PubMed ID: 28027337
[TBL] [Abstract][Full Text] [Related]
30. International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome.
Jacobs BC; van den Berg B; Verboon C; Chavada G; Cornblath DR; Gorson KC; Harbo T; Hartung HP; Hughes RAC; Kusunoki S; van Doorn PA; Willison HJ;
J Peripher Nerv Syst; 2017 Jun; 22(2):68-76. PubMed ID: 28406555
[TBL] [Abstract][Full Text] [Related]
31. Patient characteristics and the effects of intravenous immunoglobulin in patients with Guillain-Barre syndrome.
Guzey Aras Y; Tanik O; Dogan Güngen B; Kotan D
Ideggyogy Sz; 2016 Nov; 69(11-12):389-395. PubMed ID: 29733556
[TBL] [Abstract][Full Text] [Related]
32. Management of Guillain-Barré syndrome with plasmapheresis or immunoglobulin: our experience from a tertiary care institute in South India.
Kishore CK; Vijayabhaskar J; Vishnu Vardhan R; Sainaresh VV; Sriramnaveen P; Sridhar AV; Varalaxmi B; Sandeep P; Ram R; Vengamma B; Siva Kumar V
Ren Fail; 2014 Jun; 36(5):732-6. PubMed ID: 24593239
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of patients with Guillain Barre Syndrome at a tertiary care centre in Pakistan, 1995-2003.
Yakoob MY; Rahman A; Jamil B; Syed NA
J Pak Med Assoc; 2005 Nov; 55(11):493-6. PubMed ID: 16304870
[TBL] [Abstract][Full Text] [Related]
34. Predictors of long-term health-related quality of life in Guillain-Barré syndrome: A hospital-based study.
Khedr EM; Mahmoud DM; Ahmed GK; Haridy NA
Clin Neurol Neurosurg; 2023 Dec; 235():108026. PubMed ID: 37913589
[TBL] [Abstract][Full Text] [Related]
35. [Clinical features of Guillain-Barré syndrome in 41 patients admitted to a public hospital].
Cea G; Jara P; Quevedo F
Rev Med Chil; 2015 Feb; 143(2):183-9. PubMed ID: 25860360
[TBL] [Abstract][Full Text] [Related]
36. IVIG treatment and prognosis in Guillain-Barré syndrome.
van Doorn PA; Kuitwaard K; Walgaard C; van Koningsveld R; Ruts L; Jacobs BC
J Clin Immunol; 2010 May; 30 Suppl 1(Suppl 1):S74-8. PubMed ID: 20396937
[TBL] [Abstract][Full Text] [Related]
37. Severe Guillain-Barré syndrome after surgery for multiple fractures: a rare case report with a 5-year follow-up and a brief review of the literature.
Chen J; Ma JX; Zuo CH; Zhang Q; Chen HT; Ma XL
BMC Musculoskelet Disord; 2021 Jan; 22(1):8. PubMed ID: 33397348
[TBL] [Abstract][Full Text] [Related]
38. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic.
Uncini A; Vallat JM; Jacobs BC
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1105-1110. PubMed ID: 32855289
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS).
van Doorn PA
Presse Med; 2013 Jun; 42(6 Pt 2):e193-201. PubMed ID: 23628447
[TBL] [Abstract][Full Text] [Related]
40. Outcome of Guillain-Barré Syndrome in Tertiary Care Centers in Thailand.
Kulkantrakorn K; Sukphulloprat P
J Clin Neuromuscul Dis; 2017 Dec; 19(2):51-56. PubMed ID: 29189549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
